Elevation Oncology Inc. Recorded Big Gain
Thu, May 05, 2022 at 05:30 PM
Elevation Oncology Inc. (ELEV:NASDAQ) soared at $3.65, a gain of 19.7%. The stock appeared on our News Catalysts scanner on Thu, May 05, 2022 at 08:18 AM in the 'EARNINGS' category. From Thu, Apr 21, 2022, the stock recorded 55.56% Up Days and 60.00% Green Days
About Elevation Oncology Inc. (ELEV:NASDAQ)
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations.
Top 10 Gainers:
- Kaleido Biosciences, Inc. (KLDO:NASDAQ), 29.41%
- Hudson Technologies, Inc. (HDSN:NASDAQ), 26.89%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 25.04%
- Intercept Pharmaceuticals, Inc. (ICPT:NASDAQ), 21%
- Nuvectis Pharma Inc. (NVCT:NASDAQ), 20.52%
- Elevation Oncology Inc. (ELEV:NASDAQ), 19.67%
- Sonim Technologies, Inc. (SONM:NASDAQ), 19.2%
- AxoGen, Inc. (AXGN:NASDAQ), 18.28%
- Cyngn Inc. (CYN:NASDAQ), 17.98%
- Silicon Motion Technology Corporation (SIMO:NASDAQ), 17.19%